Diseases, Conditions, Syndromes

Health experts, scientists to discuss bird flu studies

The World Health Organization said Friday it will meet next week to determine whether scientists can publish research on a bird flu virus that may be easily passed among humans.

Medications

US regulators to decide on new weight loss drug

US regulators were expected to decide Tuesday whether to approve the second new anti-obesity drug in 13 years, Qnexa, which studies have shown may help some people lose up to 10 percent of their body weight.

Alzheimer's disease & dementia

FDA panel reviews 1st new Alzheimer's drug in 2 decades

One of the biggest drug decisions in decades is looming as U.S. regulators consider whether to approve the first medicine that's claimed to slow mental decline from Alzheimer's disease, the most common form of dementia.

Medications

FDA panel votes for tougher restrictions on hydrocodone

(HealthDay)—A U.S. Food and Drug Administration advisory panel met Thursday and Friday to discuss the fate of certain painkillers that contain the opioid known as hydrocodone, concluding in a vote in favor of moving hydrocodone ...

Vaccination

Top doctors say not so fast to Biden's boosters-for-all plan

Just one month ago, President Joe Biden and his health advisers announced big plans to soon deliver a booster shot of the coronavirus vaccine to all Americans. But after campaigning for the White House on a pledge to "follow ...

page 3 from 11